As of Oct 05
| +0.09 / +5.11%|
The 3 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 6.00. The median estimate represents a +386.49% increase from the last price of 1.85.
The current consensus among 4 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.